Scientific Advisory Board
CBM has brought together industry leading professionals to help advance
the development of our asset portfolio.
Dr. Tom Wilkie
To oversee clinical advancement of our asset portfolio is our Chief Science Officer, Dr. Tom Wilkie. Dr. Wilkie is an Associate Professor of Pharmacology at UT Southwestern Medical Center in Dallas. He earned his BA at UC Berkeley and PhD with Richard Palmiter at UW Seattle, both in biochemistry. Wilkie has published 74 primary research papers and reviews, serves on NIH, CIRM, and AACR grant review study sections, reviews manuscripts for multiple journals, and is Director of the first-year graduate student core course at UT Southwestern.
Dr. Timothy S. Pardee, MD, PhD
The key inventors, as well as outside experts, have all joined this effort including Dr. Timothy S. Pardee, MD, PhD, an Associate Professor of Internal Medicine, Section on Hematology and Oncology and Cancer Biology. He is the Director of Leukemia Translational Research at Wake Forest University Medical School. He is a practicing hematologist and medical oncologist with a clinical focus on the acute leukemias. In addition, Dr. Gregory Kucera is a Professor of Internal Medicine with over 28 years of research experience on novel therapeutics for cancer treatment. He has conducted research on over 25 IRB-approved clinical trials at Wake Forest. Dr. Kucera’s laboratory has expertise in synthesizing novel therapeutics, lipid biochemistry, and in vitro drug testing.
Zhengrong (Rong) Cui
Zhengrong (Rong) Cui is a Professor and Alfred and Dorothy Mannino Fellow in Pharmacy at The University of Texas at Austin (UT Austin), College of Pharmacy, Division of Molecular Pharmaceutics and Drug Delivery. He is also a member of the LIVESTRONG Cancer Institutes at UT Austin Dell Medical School. His research interests lie in drug and vaccine delivery and experimental tumor therapy. He has nearly twenty years of experience in using pharmaceutical chemistry and nanotechnology to overcome tumor resistance to (chemo)therapy, to target anti-inflammatory agents to chronic inflammation sites, and to improve the immunogenicity of vaccine antigens. He published extensively in the fields of pharmaceutics and vaccinology, including numerous peer-reviewed research papers, review papers, and book chapters. He is an inventor on several patents and patent applications that cover antitumor compounds, nucleic acid delivery systems, vaccine adjuvants, and dry powder vaccines. He teaches Biopharmaceutics to professional Doctor of Pharmacy students and Advanced Biopharmaceutics to graduate students. Dr. Cui serves as an editor of the research journal International Journal of Pharmaceutics. He holds a Ph.D. degree in Pharmaceutical Sciences from the University of Kentucky and completed his postdoctoral training at the University of Pittsburgh.
Dr. Gregory Kucera
Dr. Gregory Kucera is a Professor of Internal Medicine with over 28 years of research experience on novel therapeutics for cancer treatment. He has conducted research on over 25 IRB-approved clinical trials at Wake Forest. Dr. Kucera’s laboratory has expertise in synthesizing novel therapeutics, lipid biochemistry, and in vitro drug testing. Dr. Kucera is an inventor on 5 issued patents and is an author on over 65 peer-reviewed scientific articles and book chapters. His research has been funded by the NIH, Kucera Pharmaceutical Company, the NC Biotech Center, the NC Strategic Technology and Applied Research Initiative, and others.
Dr. Kevin Munoz
Dr. Munoz has 20 years of multifaceted experience within the industry from direct patient care as well as indirect care as operations manager. His current role is within a very busy outpatient facility helping manage patients and their musculoskeletal complaints. Dr. Munoz attended the University of Michigan where he graduated with distinction and earned a degree in Movement Science. He later went on to earn his Doctor of Medicine at Xavier University School of Medicine. It was during medical school where his passion to help and empower others developed by pioneering health fairs and initiating community outreach projects. His love of science, health, and fitness continue to influence his daily drive for optimal health.